$USNA
USANA HEALTH SCIENCES INC

2024 Q2 Form 10-Q Financial Statement

#000089626424000165 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $212.9M $227.8M
YoY Change -14.29%
Cost Of Revenue $40.33M $43.07M
YoY Change -16.87%
Gross Profit $172.5M $184.7M
YoY Change -13.66%
Gross Profit Margin 81.05% 81.09%
Selling, General & Admin $154.7M $160.1M
YoY Change 131.14%
% of Gross Profit 89.66% 86.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.813M $3.158M
YoY Change 15.58%
% of Gross Profit 2.21% 1.71%
Operating Expenses $154.7M $160.1M
YoY Change -10.58%
Operating Profit $17.84M $24.67M
YoY Change -33.54%
Interest Expense $2.712M $2.624M
YoY Change 8648.39%
% of Operating Profit 15.2% 10.64%
Other Income/Expense, Net -$349.0K -$186.0K
YoY Change -121.07%
Pretax Income $20.20M $27.11M
YoY Change -29.11%
Income Tax $9.771M $10.57M
% Of Pretax Income 48.36% 39.0%
Net Earnings $10.43M $16.54M
YoY Change -43.25%
Net Earnings / Revenue 4.9% 7.26%
Basic Earnings Per Share $0.55 $0.86
Diluted Earnings Per Share $0.54 $0.86
COMMON SHARES
Basic Shares Outstanding 19.05M shares 19.24M shares
Diluted Shares Outstanding 19.16M shares 19.30M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $332.4M $328.3M
YoY Change 12.51%
Cash & Equivalents $332.4M $328.3M
Short-Term Investments
Other Short-Term Assets $24.83M $31.86M
YoY Change -30.91%
Inventory $61.83M $60.87M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $419.1M $421.1M
YoY Change 5.86%
LONG-TERM ASSETS
Property, Plant & Equipment $97.69M $98.19M
YoY Change 0.92%
Goodwill $16.84M $16.90M
YoY Change -3.3%
Intangibles $28.64M $29.11M
YoY Change -10.43%
Long-Term Investments $20.00M $20.00M
YoY Change
Other Assets $69.18M $64.01M
YoY Change 24.41%
Total Long-Term Assets $212.3M $208.2M
YoY Change 1.28%
TOTAL ASSETS
Total Short-Term Assets $419.1M $421.1M
Total Long-Term Assets $212.3M $208.2M
Total Assets $631.4M $629.3M
YoY Change 4.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.648M $8.266M
YoY Change -36.75%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $1.320M
YoY Change
Total Short-Term Liabilities $103.9M $112.6M
YoY Change -20.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.66M $11.54M
YoY Change -25.87%
Total Long-Term Liabilities $10.66M $11.54M
YoY Change -25.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $103.9M $112.6M
Total Long-Term Liabilities $10.66M $11.54M
Total Liabilities $119.2M $129.3M
YoY Change -17.56%
SHAREHOLDERS EQUITY
Retained Earnings $463.9M $453.5M
YoY Change 13.14%
Common Stock $68.83M $65.13M
YoY Change 22.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $512.2M $500.0M
YoY Change
Total Liabilities & Shareholders Equity $631.4M $629.3M
YoY Change 4.27%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $10.43M $16.54M
YoY Change -43.25%
Depreciation, Depletion And Amortization $3.813M $3.158M
YoY Change 15.58%
Cash From Operating Activities $7.990M $17.68M
YoY Change -37.74%
INVESTING ACTIVITIES
Capital Expenditures $2.671M $3.201M
YoY Change 26.77%
Acquisitions
YoY Change
Other Investing Activities $1.125M -$867.0K
YoY Change -188.51%
Cash From Investing Activities -$1.546M -$4.068M
YoY Change -54.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.353M -$11.95M
YoY Change -57.71%
NET CHANGE
Cash From Operating Activities 7.990M $17.68M
Cash From Investing Activities -1.546M -$4.068M
Cash From Financing Activities -1.353M -$11.95M
Net Change In Cash 5.091M -$2.140M
YoY Change -27.75%
FREE CASH FLOW
Cash From Operating Activities $7.990M $17.68M
Capital Expenditures $2.671M $3.201M
Free Cash Flow $5.319M $14.48M
YoY Change -50.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
43069000 usd
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19047000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19047000 shares
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
48519000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
184731000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
199841000 usd
CY2024Q1 usna Associate Incentives
AssociateIncentives
95758000 usd
CY2023Q2 usna Associate Incentives
AssociateIncentives
106070000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64300000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
66926000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
160058000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
172996000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
24673000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
26845000 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2676000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1775000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
52000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
31000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-186000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-88000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2438000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1656000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27111000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
28501000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10574000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10118000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
16537000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
18383000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19174000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19283000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19302000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19328000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
16537000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
18383000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-5102000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
1654000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-204000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-98000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4898000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1752000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11639000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20135000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
434472000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1752000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3608000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2861000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
455354000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
497202000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4898000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3669000 usd
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
9483000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3039000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
499988000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
16537000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
18383000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3158000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3299000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1926000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1925000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-405000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3669000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3608000 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
2547000 usd
CY2023Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
3557000 usd
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
934000 usd
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
2284000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1801000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
78000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5108000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5205000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1718000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-246000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2866000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-14694000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17683000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12833000 usd
CY2024Q1 us-gaap Payments For Hedge Investing Activities
PaymentsForHedgeInvestingActivities
870000 usd
CY2023Q2 us-gaap Payments For Hedge Investing Activities
PaymentsForHedgeInvestingActivities
1271000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3201000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2107000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4068000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3378000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9444000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
537000 usd
CY2023Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3039000 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2861000 usd
CY2024Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
CY2023Q2 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
338000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11946000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3199000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-3809000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
790000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2140000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7046000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
333246000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
291320000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
331106000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
298366000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
328336000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
295454000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2770000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2912000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
331106000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298366000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
24000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
2000 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
9100000 usd
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
10182000 usd
CY2024Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
0 usd
CY2023Q2 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
517000 usd
CY2024Q1 usna Right Of Use Assets Obtained In Exchange For Lease Obligations
RightOfUseAssetsObtainedInExchangeForLeaseObligations
167000 usd
CY2023Q2 usna Right Of Use Assets Obtained In Exchange For Lease Obligations
RightOfUseAssetsObtainedInExchangeForLeaseObligations
1806000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
83000 usd
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
368000 usd
CY2024Q1 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
39000 usd
CY2023Q2 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
0 usd
CY2024Q1 usna Number Of Geographic Regions
NumberOfGeographicRegions
2 region
CY2024Q1 usna Number Of Sub Geographical Regions
NumberOfSubGeographicalRegions
3 region
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. In the opinion of the Company’s management, the accompanying interim condensed consolidated financial information contains all adjustments, consisting only of normal recurring adjustments that are necessary to state fairly the Company’s financial position as of March 30, 2024, and results of operations and cash flows for the three months ended March 30, 2024 and April 1, 2023.
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain reclassifications have been made to prior period amounts to conform to current period presentation. These reclassifications relate to the disaggregation of inventory write-downs from changes in inventories within operating activities of the condensed consolidated statements of cash flows.
CY2023Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
3137000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19790000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19848000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3646000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4707000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
37434000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
36899000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
60870000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
61454000 usd
CY2024Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
2893000 usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
3128000 usd
CY2024Q1 us-gaap Other Income
OtherIncome
718000 usd
CY2023Q2 us-gaap Other Income
OtherIncome
726000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13910000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20875000 usd
CY2024Q1 usna Increase Due To Deferral Of Revenue At End Of Period
IncreaseDueToDeferralOfRevenueAtEndOfPeriod
14824000 usd
CY2023 usna Increase Due To Deferral Of Revenue At End Of Period
IncreaseDueToDeferralOfRevenueAtEndOfPeriod
13910000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
10952000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
20875000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17782000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13910000 usd
CY2024Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1320000 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
786000 usd
CY2024Q1 us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
377000 usd
CY2023Q2 us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
968000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
16537000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18383000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19174000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19283000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
128000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
45000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19302000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19328000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
385000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
296000 shares
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
194000 shares
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
9483000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
61703000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
227800000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
248360000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
227800000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
248360000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000896264-24-000165-index-headers.html Edgar Link pending
0000896264-24-000165-index.html Edgar Link pending
0000896264-24-000165.txt Edgar Link pending
0000896264-24-000165-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usna-20240330.htm Edgar Link pending
usna-20240330.xsd Edgar Link pending
usna-20240330xex311.htm Edgar Link pending
usna-20240330xex312.htm Edgar Link pending
usna-20240330xex321.htm Edgar Link pending
usna-20240330xex322.htm Edgar Link pending
usna-20240330_def.xml Edgar Link unprocessable
usna-20240330_htm.xml Edgar Link completed
usna-20240330_lab.xml Edgar Link unprocessable
usna-20240330_pre.xml Edgar Link unprocessable
usna-20240330_cal.xml Edgar Link unprocessable